Get started
NOVARTIS NNOVARTIS NNOVARTIS N

NOVARTIS N

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

NOVN chart


Full chart

Key facts today


BNP Paribas has initiated coverage of Novartis with an 'Outperform' rating and established a price target of $116.
Analyze the impactAnalyze the impact

NOVN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪163.85 B‬ CHF
Dividend yield (indicated)
3.94%
Price to earnings Ratio (TTM)
16.64
Basic EPS (TTM)
5.21 CHF
Net income (FY)
‪10.52 B‬ CHF
Revenue (FY)
‪44.31 B‬ CHF
Shares float
‪1.69 B‬
Beta (1Y)
0.91

Employees


Employees (FY)
‪75.88 K‬
Change (1Y)
−174 −0.23%
Revenue / Employee (1Y)
‪583.96 K‬ CHF
Net income / Employee (1Y)
‪138.58 K‬ CHF

About NOVARTIS N


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Vasant Narasimhan
Website
novartis.com
Headquarters
Basel
Founded
1996
ISIN
CH0012005267
FIGI
BBG00HCYS021
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NOVN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

NOVN highest yielding bonds


US66989HAS7
NOVARTIS CAP 20/50
Yield to maturity
6.96%
Maturity date
Aug 14, 2050
NVS3904288
Novartis Capital Corp. 3.7% 21-SEP-2042
Yield to maturity
6.21%
Maturity date
Sep 21, 2042
XPND
NOVARTIS CAPITAL 15/45
Yield to maturity
6.15%
Maturity date
Nov 20, 2045
US66989HAH1
NOVARTIS CAPITAL 14/44
Yield to maturity
5.99%
Maturity date
May 6, 2044
NVS5894401
Novartis Capital Corp. 4.7% 18-SEP-2054
Yield to maturity
5.93%
Maturity date
Sep 18, 2054
NVS5894400
Novartis Capital Corp. 4.2% 18-SEP-2034
Yield to maturity
5.11%
Maturity date
Sep 18, 2034
US66989HAR9
NOVARTIS CAP 20/30
Yield to maturity
4.88%
Maturity date
Aug 14, 2030
NVS5894399
Novartis Capital Corp. 4.0% 18-SEP-2031
Yield to maturity
4.74%
Maturity date
Sep 18, 2031
XPNC
NOVARTIS CAPITAL 15/25
Yield to maturity
4.60%
Maturity date
Nov 20, 2025
NVS5894398
Novartis Capital Corp. 3.8% 18-SEP-2029
Yield to maturity
4.43%
Maturity date
Sep 18, 2029
US66989HAN8
NOVARTIS CAPITAL 17/27
Yield to maturity
4.30%
Maturity date
May 17, 2027

See all NOVN bonds 

Sparks


Curated watchlists where NOVN is featured.

See all sparks 


Check out other big names from the same industry as NOVN.

Frequently Asked Questions


The current price of NOVN is 90.20 CHF — it has increased by 3.08% in the past 24 hours. Watch NOVARTIS N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange NOVARTIS N stocks are traded under the ticker NOVN.
NOVN stock has risen by 2.22% compared to the previous week, the month change is a −8.06% fall, over the last year NOVARTIS N has showed a 4.65% increase.
We've gathered analysts' opinions on NOVARTIS N future price: according to them, NOVN price has a max estimate of 120.18 CHF and a min estimate of 73.28 CHF. Watch NOVN chart and read a more detailed NOVARTIS N stock forecast: see what analysts think of NOVARTIS N and suggest that you do with its stocks.
NOVN reached its all-time high on Sep 2, 2024 with the price of 102.72 CHF, and its all-time low was 34.40 CHF and was reached on Aug 11, 2011. View more price dynamics on NOVN chart.
See other stocks reaching their highest and lowest prices.
NOVN stock is 1.86% volatile and has beta coefficient of 0.91. Track NOVARTIS N stock price on the chart and check out the list of the most volatile stocks — is NOVARTIS N there?
Today NOVARTIS N has the market capitalization of ‪168.39 B‬, it has decreased by −11.48% over the last week.
Yes, you can track NOVARTIS N financials in yearly and quarterly reports right on TradingView.
NOVARTIS N is going to release the next earnings report on Apr 29, 2025. Keep track of upcoming events with our Earnings Calendar.
NOVN earnings for the last quarter are 1.80 CHF per share, whereas the estimation was 1.64 CHF resulting in a 9.72% surprise. The estimated earnings for the next quarter are 1.84 CHF per share. See more details about NOVARTIS N earnings.
NOVARTIS N revenue for the last quarter amounts to ‪11.95 B‬ CHF, despite the estimated figure of ‪11.66 B‬ CHF. In the next quarter, revenue is expected to reach ‪11.58 B‬ CHF.
NOVN net income for the last quarter is ‪2.47 B‬ CHF, while the quarter before that showed ‪2.76 B‬ CHF of net income which accounts for −10.52% change. Track more NOVARTIS N financial stats to get the full picture.
Yes, NOVN dividends are paid annually. The last dividend per share was 3.50 CHF. As of today, Dividend Yield (TTM)% is 3.94%. Tracking NOVARTIS N dividends might help you take more informed decisions.
NOVARTIS N dividend yield was 3.95% in 2024, and payout ratio reached 67.17%. The year before the numbers were 3.89% and 51.36% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 15, 2025, the company has ‪75.88 K‬ employees. See our rating of the largest employees — is NOVARTIS N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS N EBITDA is ‪18.90 B‬ CHF, and current EBITDA margin is 42.40%. See more stats in NOVARTIS N financial statements.
Like other stocks, NOVN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVARTIS N technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVARTIS N stock shows the sell signal. See more of NOVARTIS N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.